Cardiovascular Events Clinical Trials

16 recruitingLast updated: June 20, 2026

There are 16 actively recruiting cardiovascular events clinical trials across 10 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Beijing, Beijing Municipality, China, Tianjin, Tianjin Municipality, China, Hangzhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Cardiovascular Events Trials at a Glance

16 actively recruiting trials for cardiovascular events are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Tianjin, and Hangzhou. Lead sponsors running cardiovascular events studies include Beijing Anzhen Hospital, Brigham and Women's Hospital, and AstraZeneca.

Browse cardiovascular events trials by phase

Treatments under study

About Cardiovascular Events Clinical Trials

Looking for clinical trials for Cardiovascular Events? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiovascular Events trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiovascular Events clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Peripheral Artery DiseaseMajor Adverse Cardiovascular EventsMajor Adverse Limb Events+2 more
Centre Hospitalier Universitaire, Amiens134 enrolled1 locationNCT06318767
Recruiting
Phase 4

Statins to Prevent Cancer Associated Blood Clots

CancerVenous ThromboembolismCardiovascular Events
Brigham and Women's Hospital4,000 enrolled2 locationsNCT07303816
Recruiting

Tezspire Cardiac Events PASS

Cardiovascular EventsMACE
AstraZeneca16,640 enrolled4 locationsNCT06951867
Recruiting

Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

Major Adverse Cardiovascular EventsLeft Ventricular RemodelingPlasma Multi-Omics+2 more
Beijing Anzhen Hospital1,000 enrolled1 locationNCT06885619
Recruiting
Not Applicable

Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease

PreventionCoronary Artery Disease (CAD)Major Adverse Cardiovascular Events (MACE)+1 more
Zhang longjiang,MD3,100 enrolled1 locationNCT06843005
Recruiting
Phase 3

Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy

Myocardial Infarction (MI)Cardiovascular EventsPost Polypectomy Bleeding in Antiplatelet Patients
Chinese University of Hong Kong2,514 enrolled1 locationNCT07052799
Recruiting

The CAMAS Study: A Cross-sectional magnetic resonance imaging study on the myocardial effects of long-term anaerobic exercise using structure-function correlation

Long-term anaerobic exerciseCardiovascular Events
The University of Sydney40 enrolled1 locationACTRN12626000308392
Recruiting
Not Applicable

Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

Coronary Artery DiseaseCardiovascular EventsCT Angiography+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University3,596 enrolled6 locationsNCT06863545
Recruiting

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationCardiovascular EventsTransplant Complication
Peking University People's Hospital10,000 enrolled16 locationsNCT07349498
Recruiting
Not Applicable

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Acute Coronary SyndromeHyperlipidemiasCardiovascular Events+1 more
Nanjing First Hospital, Nanjing Medical University1,212 enrolled1 locationNCT05457582
Recruiting
Phase 3

Colchicine in Chronic Kidney Disease Patients

Chronic Kidney DiseaseCardiovascular Events
Hospital General Universitario Gregorio Marañon744 enrolled1 locationNCT06998862
Recruiting

Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA

Abdominal Aortic AneurysmCardiovascular Events
Rijnstate Hospital194 enrolled7 locationsNCT04183426
Recruiting

Evaluation of Vulnerability of Carotid Plaques and Prediction of Cardio-Cerebrovascular Event Using Ultrasonic Imaging

Ischemic StrokeCardiovascular EventsCarotid Plaque
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine600 enrolled1 locationNCT06473272
Recruiting

CCTA Improves Clinical Management of Stable Chest Pain

Stable chest painCoronary Artery DiseaseRevascularization+4 more
Tianjin Chest Hospital50,000 enrolled4 locationsNCT04691037
Recruiting

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

InfluenzaCardiovascular EventsCommunity-acquired Pneumonia
Kaiser Permanente960,000 enrolled1 locationNCT06029933
Recruiting

Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity

MenopauseAcute Myocardial InfarctionCardiovascular Events+1 more
Heinrich-Heine University, Duesseldorf180 enrolled1 locationNCT05985447